133
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Review of Acute Coronary Syndrome Diagnosis and Management

, MD, , MD, , MD & , MD, MHP, FACP
Pages 18-27 | Published online: 30 Jun 2015

References

  • Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912; 59: 2015–2019.
  • Gossl M, Versari D, Hildebrandt H, et al. Vulnerable plaque: detection and management. Med Clin North Am. 2007; 91 (4): 573–601.
  • Nawar EW, Niska RW, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data. 2007; (386): 1–32.
  • Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006; 27(13): 1523–1529.
  • Swap CJ, Nagumey JT. Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes. JAMA. 2005; 294(20): 2623–2629.
  • Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000; 283(24): 3223–3229.
  • Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007; 116(22): 2634–2653.
  • Channer K, Morris F. ABC of clinical electrocardiography: Myocardial ischaemia. BMJ. 2002; 324(7344): 1023–1026.
  • Sgarbossa EB, Pinski SL, Barbagelata A, et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med. 1996; 334(8): 481–487.
  • Wang K., Asinger RW, Marriott HJ. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med. 2003; 349(22): 2128–2135.
  • Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007; 50(7): el–el57.
  • Nagajothi N, Trivedi A. Biomarkers in acute cardiac disease. J Am Coll Cardiol. 2006; 48(11): 2358–2359.
  • Giugliano RP, Braunwald E. The year in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol. 2005; 46(5): 906–919.
  • Schuijf JD, Jukema JW, Van Der Wall EE, Bax JJ. Multi-slice computed tomography in the evaluation of patients with acute chest pain. Acute Cardiac Care. 2007; 9(4): 214–221.
  • Poon M. Technology insight: cardiac CT angiography. Nat Clin Pract Cardiovasc Med. 2006; 3(5): 265–275.
  • Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000; 101(22): 2557–2567.
  • Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003; 163(19): 2345–2353.
  • Sabatine MS, Antman EM. The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2003; 41(4 Suppl S): 89S–95S.
  • Yan AT, Yan RT, Tan M, et al. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J. 2007; 28(9): 1072–1078.
  • Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute coronary syndromes, a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol. 2006; 48: 1319–1325.
  • Murphy SA, Cannon CP, Wiviott SD, et al. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patientlevel analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). Am J Cardiol. 2007; 100(7): 1047–1051.
  • Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet. 1997; 349(9063): 1429–1435.
  • Antman EM, Anbe DT, Armstrong PW, et al. FAHAACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive xummary. J Am Coll Cardiol. 2004; 44(3): 671–719.
  • Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143–3421.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19): 2560–2572.
  • AHA; ACC; National Heart, Lung, and Blood Institute, et al. AHA/ ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006; 47(10): 2130–2139.
  • American Heart Association Nutrition Committee; Lichtenstein AH, Appel LJ, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006; 114(1): 82–96.
  • Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003; 107(24): 3109–3116.
  • Thompson PD. Exercise prescription and proscription for patients with coronary artery disease. Circulation. 2005; 112(15): 2354–2363.
  • Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of Clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001; 345(7): 494–502.
  • Schwartz GG, Olsson AG, Ezekowitz MD, et al; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001; 285(13): 1711–1718.
  • Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008; 358(6): 557–567.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.